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Abstract
Introduction: Human Papillomavirus (HPV) is the most common sexually transmitted
infection with an estimated fourteen million new cases each year in the United States
alone. HPV infections generally resolve with little or no incident, but persistent infections
can lead to more serious sequelae such as oral and cervical cancers. The Centers for
Disease Control and Prevention recommends that all 11-12 year olds receive the HPV
vaccine; yet, the prevalence of HPV vaccination in the U.S. population is far below the
prevalence of routine childhood vaccinations. Clearly, there is a public health imperative
to increase the HPV vaccination rate among American youth. Because orthodontists see
patients of the vaccination target age monthly, for 2 or more years, they are particularly
well positioned to influence vaccination rates by educating patients and their parents
about HPV and the HPV vaccine. Therefore, the goals of this study were to examine the
determinants of orthodontists’ willingness to provide an HPV educational intervention to
adolescent patients, and orthodontists’ agreement that HPV is within the scope of
orthodontic practice. Methods: A survey instrument informed by the Integrated Behavior
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Model of health behaviors was used to obtain cross-sectional data from a representative
sample of Florida Orthodontists’ that assessed personal and practice demographics,
knowledge regarding HPV and the HPV vaccine, and their willingness to provide an
HPV educational intervention. Univariate, bivariate, principle component, and
multivariable logistic regression analyses were used to evaluate the specific aims.
Results: For each year that participants’ aged, the adjusted odds of willingness increased
12% (AOR = 1.12, 95% CI 1.02, 1.23). Additionally, those participants who agreed that
HPV causes cancer in females, were four times more willing to provide an HPV
educational intervention than those who disagreed (AOR = 4.07, 95% CI 1.51, 10.94).
Perceived Control (AOR = 2.03, 95% CI 1.06, 3.90), and Salience (AOR = 3.09, 95% CI
1.35, 7.09) were also significant determinants of orthodontists’ willingness to provide an
HPV educational intervention. The amount of office time respondents were willing to
provide to deliver HPV information to patients was a significant predictor of agreement
that HPV was within the scope of orthodontic practice; less than 1 minute (AOR = 7.55,
95% CI 1.09, 52.33), 1-2 minutes (AOR = 21.20, 95% CI 3.44, 130.52), and 3-4 minutes
(AOR = 41.05, 95% CI 6.04, 279.12). Neither self-rated knowledge nor agreement that
HPV is within the scope of orthodontic practice, were significant determinants of
orthodontists’ willingness to provide an HPV educational intervention. In addition,
encouragement to discuss HPV or recommend the HPV vaccine during professional
education were not significant predictors of respondents’ agreement that HPV is within
the scope of orthodontic practice. Conclusions: Our findings suggest an opportunity to
impact orthodontists’ willingness to provide an HPV educational intervention through
encouraging orthodontists to discuss HPV and the HPV vaccine effectively in
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professional school and continuing education, the availability and dissemination of
informational pamphlets, and support and guidance from the American Association of
Orthodontists (AAO). Also, support and guidance from the AAO may promote
orthodontists’ understanding that HPV is within the scope of orthodontic practice.
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Chapter 1: Introduction
1.1. Background
1.1.1. The Human Papillomavirus
Human Papillomavirus (HPV) is the most common sexually transmitted virus that
infects most men and women at some point in their lives.1 It is estimated that there are
more than fourteen million new cases of HPV each year in the United States.1 While most
infections resolve spontaneously, HPV can cause a number of health sequelae that range
from benign warts to invasive cancers.1,2 HPV plays a prominent role in the development
of cervical cancer, the second most prevalent cancer among women.3 The incidence and
prevalence of different HPV-related cancers vary by sex and race/ethnicity. The United
States Centers for Disease Control and Prevention (CDC) cancer registry data reveals a
higher incidence of HPV-related cervical cancers among black and Hispanic women than
women of other race/ethnicities.4 Similarly, the incidence of HPV-related vaginal cancers
are greater in Black and Hispanic women than others, while white women exhibit a
higher incidence of HPV-related vulvar cancers.4

HPV is particularly pertinent for oral health professionals because it has been
identified as an etiologic agent for oropharyngeal cancers.5 A case study in the United
States that examined 130 individuals with newly diagnosed oropharyngeal cancers found
that 63% were attributable to HPV infection.6,7 As with HPV-associated genital tract
cancers, studies have also demonstrated that the incidence and prevalence of HPV-related
oropharyngeal cancers vary by race/ethnicity and sex. Higher incidence of HPV-related
oropharyngeal cancers exist among non-Hispanic whites compared to Hispanics and non-

1

Hispanic blacks. Moreover, the incidence of HPV-related oropharyngeal cancers is higher
for men than for women.4 According to the CDC, between 2008 and 2012, approximately
1:10,000 males and 1:50,000 females were diagnosed with an HPV-associated
oropharyngeal cancer in the state of Florida alone.8 These statistics are particularly
discouraging considering that preventative vaccines have been available since 2006.1

1.1.2. The Human Papillomavirus - Microbiology & Pathogenesis
The Human Papillomavirus is composed of small, circular, non-enveloped double
stranded DNA that infects both cutaneous and mucosal epithelium.2,9 There are over 200
strains of the HPV virus that are each differentiated by a genetic sequence found in their
outer protein capsule.2,9 HPV viruses are further categorized by morbidity / oncogenicity,
as either low-risk / non-oncogenic, or high-risk / oncogenic.2 The non-oncogenic strains
include HPV-6 and HPV-11 and have been implicated in benign lesions such as genital
warts, while oncogenic strains include HPV-16 and HPV-18 and have been identified as
etiologic agents for cervical and oropharyngeal cancers.2 Specifically, HPV-16 is the
cause of approximately 50% of cervical cancers worldwide, and HPV-16 and HPV-18
together account for about 70% of cervical cancers.10 Likewise, 90% of HPV-positive
oropharyngeal cancers are associated with HPV-16 and HPV-18.6,11-14 Oncogenic strains
of the HPV virus integrate into the host’s genome and produce oncoproteins that in turn
target and destroy tumor suppressor genes TP53 and RB1 that allow the virus to
proliferate.15
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Transmission of the virus is predominantly through skin-to-skin contact with an
infected individual.1 Infected individuals most commonly transmit the HPV virus through
vaginal or anal sexual intercourse; however, it is also transmitted through oral sex and
open-mouth kissing.1,16 The virus is latent in most people, producing no clinical signs of
infection. In such cases, the virus is usually cleared by host immune response in six to
twenty-four months.1,9,15 A small percentage of individuals do become symptomatic.15
Genital warts are the most common clinical manifestation of the HPV virus and occur in
1% of the sexually active U.S. population. Other clinical manifestations of the HPV virus
include anal warts, recurrent respiratory papillomatosis, cervical intraepithelial neoplasia,
and more serious malignancies including vaginal, cervical, penile, anal, and
oropharyngeal cancer.2

1.1.3. The Human Papillomavirus – Vaccinations and Guidelines
There is no treatment for existing HPV infections; however, The United States
Food and Drug Administration (FDA) has approved three vaccines that can prevent
infection of several oncogenic HPV strains. Cervarix is a bivalent intramuscularly
administered vaccine, indicated for females, that evokes an immune response against
HPV-16 and HPV-18.17 The Cervarix regimen involves three doses; the second dose one
month and third dose six months following the initial dose.17 Gardasil, is a quadrivalent
vaccine that protects against HPV strains 6, 11, 16, and 18.9 Gardasil, indicated for both
males and females, is also administered via intramuscular injection.9,18 The Gardasil
vaccine is also delivered in three doses, following the same regimen as Cervarix.18
Gardasil 9, a 9-valent vaccine, also indicated for males and females, not only imparts
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immunity for all HPV strains targeted by Cervarix and Gardasil, but also HPV strains 31,
33, 45, 52, and 58.1 Gardasil 9 is administered intramuscularly in either a two-dose or
three-dose regimen.19

The CDC recommends HPV vaccination for males and females between the ages
of 11-12 years.1 This is the age group when children often begin experimenting sexually
and are likely exposed to HPV.1 A study by Finer and Philbin concluded that
approximately 1% of 11-12 year old children engaged in sexual intercourse, however,
Finer and Philbin did not examine other forms of sexual interaction, such as oral and anal
sex.20 As such, it is likely that Finer and Philbin’s study underestimated the prevalence of
sexual activity among 11-12 year old children and by extension, those susceptible to
exposure. Importantly, studies have shown HPV vaccines are most efficacious if they are
administered before children become sexually active and not efficacious once they have
contracted the virus.6

1.1.4. The Human Papillomavirus Vaccine Safety and Efficacy
Each of the three vaccines recommended by the CDC and approved for use by the
FDA are safe, when administered with awareness of the contraindications and their
possible adverse reactions. Contraindications to vaccine administration include allergic
reactions to vaccine components or a previous HPV vaccine, moderate or severe acute
illnesses, and pregnancy.2,21 Acute adverse reactions include fever, local cutaneous
responses at injection sites, such as pain, redness, swelling, and syncope following
injection.2, 17-19 With respect to long-term adverse reactions, a three-year study evaluated
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individuals following vaccination with Gardasil and found that with the over 600,000
doses administered, there were no increased risks of Guillian-Barre Syndrome, stroke,
venous thromboembolism, appendicitis, syncope, allergic reactions, or anaphylaxis.22

Serious side effects have been reported to rarely occur after HPV vaccination. The
U.S. Department of Health and Human Services (DHHS) formed The National Vaccine
Injury Compensation Program (VICP) to address vaccination injuries. The VICP entitles
seriously injured individuals to compensation.23 The DHHS determines whether the cause
of the individual’s injury was due to vaccination, by reviewing a petition from the injured
individual submitted to the VICP.23 After a review of information presented by the
petitioner and the DHHS, the United States Court of Federal Claims issues a final
ruling.23 The Health Resources and Services Administration (HRSA), a division of the
DHHS, reports the frequency of serious complications due to all vaccines, including the
HPV vaccine.23 From 2006 to 2015, only 13 of the approximately 89,696,704 doses of
the HPV vaccine that were administered to the U.S. population resulted in injury that lead
to a financial award to the injured individuals.23 Similarly, 23 of the approximately
88,814,104 doses of the common childhood vaccination DTaP resulted in injury that lead
to a financial award to the injured individuals.23 The HPV vaccine seemingly compares
favorably with the safety observed among the routine DTaP vaccination.

The CDC has deemed HPV vaccines highly efficacious with over 99% of
recipients developing antibody responses to target genotypes one month after completing
the appropriate dosing regimen.2 These vaccines provoke an immune response targeted
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towards particular HPV strains, however, vaccine efficacy is dependent upon whether or
not the individual was exposed to the specific HPV strains before vaccination. The
vaccines have no therapeutic effect on pre-existing HPV infections.2 A long-term study
demonstrated that females vaccinated at ages 10-14 years maintained seropositivity up to
seven years after immunization with the bivalent HPV vaccine, Cervarix.24 Another
study, including females and males ages 9-15 years, demonstrated persistent
seropositivity eight years after immunization with the quadrivalent HPV vaccine,
Gardasil.25 The seropositivity observed in these studies demonstrated that long-term
immunogenic response was elicited by both of these HPV vaccines.

1.2 The Human Papillomavirus Health Impact
1.2.1. Low Vaccination Rates
The CDC Advisory Committee on Immunization Practices (ACIP) recommends
that adolescents between the ages of 11-12 years receive routine vaccination for tetanusdiphtheria-pertussis (DTaP), meningococcal disease, and HPV.26 The ACIP recommends
the administration of the HPV vaccine together with the DTaP and Meningococcal
vaccines in a single visit to promote higher HPV vaccination rates, because coadministration does not negatively impact the immunogenicity of the vaccines.27 Despite
this recommendation, in 2016 only 49.5% of adolescent females and 37.5% of adolescent
males had completed the HPV vaccination series, while vaccination coverage of males
and females aged 13-17 years for ≥1 dose of the DTaP and Meningococcal vaccines were
88.0% and 82.2%, respectively.26 It is not clear why a disparity in vaccination rates exists
given that these vaccines are all equally safe and all recommended by the ACIP.
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1.2.2. Potential Facilitators and Barriers
To effectively increase HPV vaccination rates in this country, public health
research must identify the barriers and facilitators that impact vaccine-related discussions
/ recommendations and vaccine administration. An understanding of these barriers and
facilitators provide opportunities for targeted public health interventions. In a recent
study, Gilkey et al.,28 assessed physician communication about adolescent vaccination
for HPV. 28 Gilkey et al.,28 reported that pediatricians and family physicians viewed
discussions of HPV vaccination as burdensome, garnering less parental support, and
lasting twice as long as discussions about other vaccinations.

Educating patients and parents about HPV will likely lead to increased HPV
vaccination uptake. One study of male students at a two-year college in New York City
reported that HPV knowledge was low but that acceptability of the vaccine was high.29
The authors suggested that since individuals are amenable to receiving the vaccine,
perhaps the low vaccination rates are due to deficiencies in doctor-patient communication
about HPV.29 The authors speculated that a dialogue between providers and their patients
to increase HPV awareness, would promote an increase in vaccination rates.29 Similarly,
Bertram and Niederhauser30 observed that male and female college students in Hawaii
knew little about HPV or the virus’s relationship to cancer. Their study reported
confusion among students regarding the differences between high and low risk HPV
strains and the respective health sequelae.30 Bertram and Niederhauser30 highlighted a
need for healthcare providers to discuss HPV with their patients to increase patients’
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awareness. Clearly, an opportunity exists for all health professionals to play a role in
HPV education and prevention.

Evidence that HPV causes oral and oropharyngeal cancers highlights the
important role for dentists in prevention of HPV infection.5,6,9,31 To date, among the small
number of studies that have focused on HPV provider/patient discussions, fewer have
considered the potential role of dentists or dental specialists. Among the few studies that
have considered a role for dentists, Daley et al.,32 found that more than 52% of the
Florida general dentists surveyed, reported no intention to discuss the HPV vaccine with
female patients. Daley et al.,32 found that dentists declined to discuss the HPV vaccine
with patients because of discomfort discussing sexual health related topics, a lack of
guidelines or oversight from dental professional organizations, and that dialogue
regarding HPV was viewed as outside the scope of dental practice. As dental specialists,
orthodontists’ likely share the same aversions to discussing HPV vaccination as their
general dental colleagues. Yet, it is important to recognize that because the orthodontic
patient population is predominantly adolescent, efforts by orthodontists to increase HPV
vaccine rates among their patients may be among the most impactful of all public health
efforts to increase the HPV vaccination rates. In fact, according to Shapiro,33 an
orthodontist’s recommendation for HPV vaccination was more important than a
physician’s recommendation, as a predictor of patients’ parents’ willingness to permit
their child to receive the HPV vaccine.
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1.2.3. The Orthodontists’ Impact
In 2014, 83% of children aged 2-17 years had visited a dentist (including
specialists such as orthodontists) in the past year.34 As such, dentists are among the most
frequently visited healthcare providers annually,34 and have an opportunity to provide
important educational information about HPV and the need to vaccinate that, to date, has
been overlooked. Given that the majority of orthodontic patients are adolescents, the
optimal age targeted by the CDC for HPV vaccination, among all dentists, orthodontists
are perhaps the best positioned to provide important educational information about HPV
and recommend vaccination. In 2014, American Association of Orthodontists (AAO)
members in the U.S. and Canada treated a total of 5,419,000 patients.35,36 Seventy-three
percent (3,959,000) of these patients were 17 years of age or younger.35,36 Patients
generally visit the orthodontist once per month for two consecutive years. As such, there
is repeated, frequent contact between orthodontists and their patients. Such contact
provides opportunities for orthodontists to have discussions with patients, aimed towards
increasing HPV vaccination uptake. Clearly, orthodontists have a unique opportunity
and a responsibility to contribute to public health interventions to reduce the prevalence
of HPV infection and associated cancers that are targeted towards their patients, the
population most at risk. Yet according to Daley et al.,32 dentists, and likely orthodontists,
are hesitant to do so. Therefore, it is important to identify the barriers and facilitators
determining orthodontists’ willingness to discuss HPV with their patients in order to
capitalize on their potential impactful role in HPV prevention. However, to our
knowledge, previous studies have not yet examined the determinants of orthodontists’
willingness to discuss HPV with patients.
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1.3 Models of Behavior
It is important to understand whether orthodontists currently discuss HPV with
patients and their parents and if not, then it is necessary to examine the determinants of
their willingness to do so. Psychological models of health behavior are designed to
explain a wide range of health behaviors by emphasizing that intent is the best predictor
of performing a behavior.37 The psychological constructs of health behavior models
permit an understanding of the determinants of behavioral intent that can then be used to
target and implement effective interventions to change behaviors.37 One such
psychological model is the Integrated Behavior Model (IBM). The IBM is an extension
of the Theory of Reasoned Action (TRA) and the Theory of Planned Behavior (TPB).37
The IBM was used in this study to inform our survey instrument in order to identify the
determinants of orthodontists’ willingness to provide an HPV educational intervention to
their patients and agreement that HPV is within the scope of orthodontic practice (Figure
1). In this context, “educational intervention” was defined as delivery of information
related to HPV and the HPV vaccine via discussion with patients and parents, delivery of
instructional videos or pamphlets.

1.3.1. History and Background – Psychological Health Behavior Models
The TRA was proposed by Martin Fishbein38 in 1967 and emphasized that the
best predictor of behavior is behavioral intention. The two constructs Fishbein described
that influence intention were attitude and subjective norm.38 Attitude is described as a
person’s overall favorableness or unfavorableness towards performing a behavior and an
individual’s attitude is a direct determinant of their behavioral intention.38 Fishbein’s
10

second construct, subjective norm, describes how the pressure one feels in social
interactions influences their intent to perform or not perform a particular behavior.38

The TPB, postulated by Icek Ajzen39-41 in 1985, improved upon the TRA by
including the construct of perceived control over the performance of a behavior.
Perceived control describes one’s perceived ability to perform a behavior, after taking
into account environmental factors that may make it easy or difficult to perform that
behavior.39 The TRA and TPB have been used for decades to explain health behaviors,
including smoking, drinking, exercise, and the performance of health professionals.37,42
Just as the TPB developed as a more explanatory extension of the TRA, the IBM is
viewed as a more comprehensive extension of the TPB with the addition of constructs
such as knowledge, salience, environmental constraints, and habits that increase our
understanding of health behaviors.37
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Figure 1: Theory of Reasoned Action (TRA) and Theory of Planned Behavior (TPB).37
The unshaded boxes model the TRA while the unshaded boxes together with
the shaded boxes model the TPB.

1.3.2. The Integrated Behavior Model
The IBM, illustrated in Figure 2, is a validated model that, like the TRA and TPB,
postulates intent as the best predictor of behavior.37 Like previous models, the IBM
includes three constructs that directly influence behavioral intent, attitude, normative
beliefs, and control beliefs.37 In the IBM, attitude is subdivided into experiential attitude
and instrumental attitude.37 Experiential attitude is one’s emotional response to the idea
of performing a behavior while instrumental attitude is determined by beliefs about the
outcomes of a behavior.37 Perceived norm is subdivided into injunctive norm and
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descriptive norm.37 Injunctive norm involves beliefs about what others think one should
do while descriptive norm involves perceptions about what others in one’s social or
personal networks are doing.37 Personal agency has two components including selfefficacy and perceived control.37 Self-Efficacy involves the confidence needed to perform
a behavior in the face of challenges and perceived control as previously explained, is
ones perceived amount of control over behavioral performance.37 The IBM introduces
four additional constructs that directly affect behavior; knowledge, salience,
environmental constraints, and habits.37 These four constructs that impact behavior
directly, reflect findings that an observed behavior is more likely to be performed if one
has the knowledge and skills necessary to execute the behavior, the behavior is deemed
important, there are no environmental influences preventing the behavior, and the
behavior has been performed previously.37
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Figure 2: Integrated Behavior Model (IBM).37
1.4. Current Study
1.4.1. Purpose
HPV’s etiologic role in oral and oropharyngeal cancers demands that dentists and
dental specialists be proactive, armed with knowledge, and effectively communicate with
patients and their parents about the pathogenicity of the virus and availability of
prophylactic vaccines.31 The prevalence of HPV vaccination in the U.S. population is far
below the prevalence of routine childhood vaccinations.26 Because the majority of
orthodontic patients are the primary target age for HPV vaccination and are seen by the
orthodontist on a frequent, long-term basis during orthodontic treatment, this study
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examined the determinants of orthodontists’ willingness to provide an HPV educational
intervention to adolescent patients, and orthodontists’ agreement that HPV is within the
scope of orthodontic practice.

1.4.2. Specific Aims
Specific Aim 1: To describe the prevalence of Florida Orthodontists’ willingness to
provide patients with an HPV educational intervention and/or administer
the HPV vaccination.
Specific Aim 2: To examine the association between Florida Orthodontists’ self-rated
knowledge of HPV and the HPV vaccine with their willingness to provide
patients with an HPV educational intervention.
Hypothesis 1: Orthodontists’ willingness to provide patients with an HPV
educational intervention will increase with greater self-rated
knowledge of HPV and the HPV vaccine.
Specific Aim 3: To examine the association between Florida Orthodontists’ agreement
that HPV is within the scope of orthodontic practice and their willingness
to provide patients with an HPV educational intervention.
Hypothesis 2: Orthodontists’ willingness to provide patients with an HPV
educational intervention will increase with agreement that HPV is
within the scope of orthodontic practice.
Specific Aim 4: To examine the association between Florida Orthodontists’
encouragement during their professional education to either discuss HPV
with their patients or recommend the HPV vaccine, and agreement that
HPV is within the scope of orthodontic practice.
Hypothesis 3: Orthodontists’ agreement that HPV is within the scope of
orthodontic practice will increase with encouragement during their
professional education to either discuss HPV with their patients or
recommend the HPV vaccine.
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Chapter 2: Materials and Methods
2.1. Study
This cross-sectional study used data obtained from a survey administered to a
representative sample of Florida Orthodontists. The survey instrument, informed by the
IBM, was used to assess these orthodontists’ personal and practice demographic
characteristics, knowledge regarding HPV and the HPV vaccine, orthodontists’
willingness to provide an HPV educational intervention to adolescent patients, and
agreement that HPV is within the scope of orthodontic practice. We examined the
determinants of orthodontists’ willingness to provide an HPV educational intervention
and agreement that HPV is within the scope of orthodontic practice.

2.2. Participants
The sampling frame was derived from an exhaustive search of the AAO
membership directory for the state of Florida and the Yellow Page listings for each
county in Florida. The combined list was cross-checked for duplicate entries resulting in
a comprehensive listing of all Florida Orthodontists, both non-members and members of
the AAO. The sample of prospective participants for this study was a representative
sample of 474 orthodontists selected from the sampling frame. The inclusion criteria for
study participants were as follows: English speaking orthodontists, who graduated from a
CODA accredited postgraduate orthodontic program, and who were actively practicing in
the state of Florida at the time of this study in February 2017. Individuals, who did not
meet the inclusion criteria, as well as, orthodontists that served as full-time faculty at the
Nova Southeastern University, College of Dental Medicine, Department of Orthodontics
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at the time of this study, were excluded. The resulting sample included 15 (3%)
participants without and 459 (97%) with membership in the AAO (Figure 3). Each
participant was assigned a unique six-character (three-letter and three-digit) identifier for
anonymity and tracking purposes.

Figure 3: American Association of Orthodontists membership
status within the study sample
2.3. Focus Group Procedures
Ten participants were selected and agreed to partake in focus group interviews
during development of the survey instrument. Five of the ten participants were randomly
selected from the sample of 474 orthodontists currently practicing in the state of Florida
using a web-based random number generator. The remaining five were selected by
convenience from among the Florida Orthodontists that currently serve as adjunct faculty
members in the Department of Orthodontics within the College of Dental Medicine at
Nova Southeastern University. Adjunct faculty members were not included in the original
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sample of 474 orthodontists currently practicing in the state of Florida. Focus group
participants were excluded from participating in the survey.

According to Fishbein,43 the beliefs underlying a particular health behavior may
be different for different populations. Therefore, an elicitation phase was a requirement
for survey design to ensure that the survey was valid for the intended target population.43
The elicitation phase for our study consisted of open-ended telephone interviews that
identified beliefs of our sample population to permit appropriate measurement of
constructs of the IBM within our survey instrument.37 Specifically, interviews assessed
attitudes towards performing and the outcome of performing an HPV educational
intervention, the impact other individuals or groups may have on performing an HPV
educational intervention, and certain facilitators or barriers to delivery of an HPV
educational intervention.37 This information helped to specify questionnaire content.37
Focus group interviews were also used to confirm face validity by asking participants
questions such as, “Do you understand what this item is asking you? Why or Why not?”
and “Do you feel confident that the responses you gave accurately represent your views,
beliefs, or opinions? Why or why not?”

2.3. Survey Instrument
The 29 item survey instrument used in this study was informed by the IBM.37
Survey instrument design, with respect to content validity, item content, construction, and
response scales, was based upon recommendations from experts and the literature
regarding the use of the IBM.37,44 Completion of the self-administered survey instrument
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required ten to fifteen minutes of the participant’s time and was completed in one sitting.
Study participant responses were submitted by either return of the mailed hardcopy
survey instrument or by electronic submission on the REDCap website, an online
application for construction, administration, and management of digital survey
instruments. Hardcopy responses were entered manually into a Microsoft Excel
spreadsheet individually, by both the principal investigator and a research assistant, and
the data was later compared for accuracy. Electronic submissions were automatically
recorded in REDCap and exported as an Excel spreadsheet. Finally, hardcopy and
electronic response spreadsheets were merged and used for data analysis. Participant
email addresses and contact information were disassociated from survey response data
and stored in a file on a separate password protected university server.

2.5. Solicitation and Recruitment
Dillman’s Total Design Method (TDM) informed the survey administration for
the current study.45 The TDM includes a prescribed series of contact communications
with prospective participants in order to maximize survey response rates.45 The initial
contact prescribed by the TDM, is a mailed cover letter outlining the purpose of the study
along with the survey instrument.45 One-week later, a reminder postcard is sent, followed
by an additional questionnaire booklet three weeks and seven weeks after the initial
mailing to non-respondents.45 Survey administration in our study followed a modification
of the TDM, both in contact modalities and communications timing.

Communication with prospective participants utilized a series of structured
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mailings and emails administered by REDCap. Postal and email addresses were acquired
from the AAO membership directory and the Yellow Page listings. An initial hardcopy
mailing contained an introductory letter, informed consent statements, and hardcopy of
the survey instrument with a pre-addressed, stamped envelope to return the survey.
Subsequent REDCap emails included an invitation to participate with an explanation of
the study and its purpose, as well as an embedded hyperlink to the electronic informed
consent and survey instrument that was housed on the REDCap website. A 4”x 6”
reminder postcard included an invitation to participate with an explanation of the study
and its purpose, as well as a REDCap web address to permit informed consent and
completion and submission of the survey instrument. Following acceptance of the
informed consent, respondents were provided the self-administered survey instrument.
Individuals wishing to decline participation in the study could withdraw at study
initiation or opt-out from the study at any time without consequences. Incomplete survey
instruments were included in the study. All communications with prospective participants
included the primary investigator’s contact information so that participants could ask
questions if necessary at any time during the study.

Contact communications were staged to allow ample participant response time but
amended from those communications prescribed by the TDM. At each step in the
communication process, prospective participants were thanked for their time and effort to
participate, and contribution to furthering an important research effort. In addition,
participant identifiers were used at each stage of communication only to ensure that those
who had previously submitted survey responses were excluded from all further
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communications. Two weeks following the initial mailing, the principal investigator sent
a solicitation email, followed by two additional solicitation emails, each at two-week
intervals, to non-respondents via the REDCap website. One week following the final
email, a postcard was sent to non-respondents to encourage participation. A final
telephone call to non-respondents was placed two weeks following the postcard mailing
to request submission of either the hardcopy or emailed survey.

To encourage participation and to acknowledge and thank individuals for their
time and effort in advancing our research endeavors, opportunities to enter a drawing
were provided as incentives. Incentives were offered to those who participated in the
focus group elicitation phase and to participants who completed the survey. The
incentives offered were entries into a drawing for a 42mm Apple iWatch at the
completion of the study. The number of drawing entries granted depended upon the
solicitation stage when each participant submitted a completed survey. Each participant’s
random 6-character alphanumeric identifier was used to track survey submission in
relation to the stage of solicitation in order to appropriately assign drawing entries. Each
drawing entry for each participant was recorded by saving the participant’s alphanumeric
identifier to a single row, in the first column of a Microsoft Excel spreadsheet. Multiple
drawing entries were recorded by saving the participants’ alphanumeric identifier on
multiple rows in the same column of the spreadsheet.

The method of awarding drawing entries for each solicitation stage was as
follows. One entry was provided for those who participated in the focus group elicitation
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interviews. Participants received a single entry into the incentive drawing after
completing the hardcopy survey or first emailed survey. Two drawing entries were
awarded for completion of the second and third emailed surveys. Following the
dissemination of the third solicitation email, fewer responses were received from study
participants than anticipated. The principle investigator and research assistants
subsequently placed telephone calls to non-respondents in order to confirm email
addresses and encourage participation. A fourth and final solicitation email was then sent
one week following the third email. Three drawing entries were awarded for completed
surveys received following the final solicitation email. One week following this final
email, a postcard was sent to non-respondents to again encourage participation. Five
drawing entries were awarded for completed surveys received following the reminder
postcard. The principal investigator and research assistants placed a final telephone call
to non-respondents, two weeks following the postcard mailing, to request submission of
either the hardcopy or emailed survey. Ten drawing entries were awarded for completed
surveys received after the final telephone solicitation. Following the study, one identifier
was randomly selected from this column using a web-based random number generator,
the study participant was contacted and the Apple iWatch incentive was awarded. The
institutional review board of Nova Southeastern University approved our study design,
methods, and protocols.

2.6. Dependent Variables
For Specific Aim 1, prevalence was measured by a survey item response to
whether orthodontists would be willing to provide an HPV educational intervention
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and/or administer the HPV vaccine to their patients, based on a 4-point Likert scale
dichotomized to “willing” vs. “un-willing”. The dependent variable for Specific Aims 2
and 3 was also the dichotomized “willingness” Likert response to the survey item that
assessed whether orthodontists would be willing to provide patients with an HPV
educational intervention. For Specific Aim 4, the dependent variable was measured by a
survey item response to whether orthodontists agreed HPV was out of the scope of
orthodontic practice, based on a 4-point Likert scale dichotomized to “agree” or
“disagree”. For ease of interpretation, this variable was then recoded to assess agreement
that HPV was within the scope of orthodontic practice.

2.7. Independent variables
For Specific Aim 2, the primary independent variables of interest were measured
by survey item responses to orthodontists’ self-rated knowledge of HPV and the HPV
vaccine based upon a 4-point Likert scale dichotomized to “none or limited” vs.
“moderate”, “good”, or “excellent”. The primary independent variable of interest for
Specific Aim 3, was a response to whether orthodontists agree HPV was out of the scope
of orthodontic practice, measured by a Likert scale, dichotomized to agree or disagree.
For ease of interpretation, this variable was then recoded to assess agreement that HPV
was within the scope of orthodontic practice. For Specific Aim 4, the primary
independent variable of interest was measured by a survey item response to assess
Florida Orthodontists’ encouragement during their professional education to either
discuss HPV with their patients or recommend the HPV vaccine dichotomized to “yes” or
“no”.
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Additional independent variables included respondents’ sociodemographic
characteristics (age, sex, race/ethnicity), characteristics of respondents’ orthodontic
practices (years in practice, practice setting, number of patients treated daily, and the
number of patients treated that are ≤17 years or ≥18 years of age), and responses to
survey items informed by the domains of the IBM. The IBM domains used included
Perceived Norm (Injunctive Norm), Knowledge, Personal Agency (Self-Efficacy and
Perceived Control), Salience, and Environmental Constraints.

2.8. Statistical Analysis
The study included univariate, bivariate, principle component, and multivariable
logistic regression analyses. The univariate analysis described the socio-demographic and
background characteristics of our sample by reporting the means and standard deviations
of the continuous variables and frequencies and proportions of categorical variables. The
bivariate analyses evaluated the unadjusted associations between the two dependent
variables and each of the independent variables. Principle component analysis was
employed to identify if groups of seemingly correlated observed variables (survey items)
could be transformed into linear combinations of optimally weighted observed variables
creating artificial variables, known as principal components, that explain most of the
variance of the observed variables. Factor scoring was used to weight the contribution
each observed variable made to the constructs and then the resulting principal
components were assessed to determine if they could be identified as constructs of the
IBM. The multivariate logistic regression analyses examined associations between
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dependent variables and the independent variables of interest and covariates (including
principal components) as outlined in the specific aims. Multivariable model building
began by initially including independent variables demonstrating an unadjusted bivariate
association with the dependent variable with a p-value ≤ 0.25. Each of the models were
further reduced in a stepwise fashion, resulting in the most parsimonious model with best
model fit and explanation of variance in the dependent variable, following the method
outlined by Hosmer and Lemeshow.46 Sociodemographic and practice characteristic
variables were forced into the regression models to control for potential confounders,
independent of p-values. Robust standard errors were utilized in the process in order to
accommodate problems of normality, heteroscedasity, and observations that exhibited
large residuals, leverage, or influence.

Multivariable logistic regression (MLR) analysis was used to examine all
dichotomous outcomes. Pass 14 software (NCSS, LLC, Kaysville, Utah) that employs
Hsieh’s power estimation method47 was used for our power analysis. The power
calculation assumed a sample size of 450 participants and an unadjusted baseline
proportion of orthodontists’ willingness to provide an HPV educational intervention of at
least P0 = 0.50, demonstrated by a similar study.42 We estimated the smallest effect size
(i.e., odds ratio), detectable as a function of power for one dichotomous dependent
variable and as many as 10 covariates (Figure 4). The MLR analyses are estimated to
detect OR’s from 1.71 to 1.79, comparable to Cohen’s “d” small effect size48 with a
power of 80%, and larger effect size detection is estimated with power greater than 80%.
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Figure 4: Power calculation for multiple logistic regression
analysis. Odds ratio (OR) = 1.71 -1.79 detectable with
80% power (for R2 = 0.01 – 0.16, respectively).
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Chapter 3: Results
3.1. Participation Summary
Among the 469 Florida Orthodontists recruited to complete a survey instrument,
119 responded with completed surveys, resulting in a 25.4% response rate. The majority
of participants completed the hardcopy survey (64%) while the remainder completed the
web-based version (36%). The incentive offered upon response submission was an entry
or entries into a drawing for a 42mm Apple iWatch at the conclusion of the study. As
described above, the number of entries was dependent upon the stage of solicitation at
which the completed survey was received. Accordingly, 72% of respondents received one
entry, 19% of respondents received two entries, 4% of respondents received three entries,
1% received five entries, and 3% of respondents were awarded ten entries into the lottery
in appreciation of their participation.

3.2. Descriptive Statistics
Descriptive statistics provide a summary of the participants in our study and are
presented in Table 1. The majority of these participants were male (63%) with an average
age of 48.6 years. Whites were the most represented racial group (86%) followed by
Other (7%), Asian (4%), and Black (3%) and regarding ethnicity, 16% were
Hispanic/Latino.

The participants in our study had practiced an average of 18-years, and more than
half (54%) graduated from their residencies after the year 2000. Nearly three-fourths of
respondents were in solo practices (74%), almost all reported working in a private
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practice setting (96%) and in urban areas (92%). More than a third of participants (37%)
reported daily patient volume between 51-75, followed by 30% who reported between
26-50 patients per day, while 17% reported practices, with more that 75 patients per day.
Additionally, participants reported that the majority of patients in their practices (72%)
were 17 years of age or younger.

Less than 11% of respondents reported having none/limited self-rated knowledge
of HPV and its modes of transmission. Evidence of our participants’ baseline knowledge
was observed by the high percent of participants who recognized that HPV causes cancer
in females (95%) and males (80%), is sexually transmitted (93%), and is preventable
(97%). While 68% of respondents reported learning about HPV during their education,
only 11% were encouraged to either discuss HPV with, or recommend the HPV vaccine
to their patients during professional training. Additionally, more participants reported a
moderate, good or excellent level of self-rated knowledge of routine childhood
vaccinations (88%) compared to that of the HPV vaccines (73%).

Most participants reported that they needed additional knowledge about HPV
prevention (86%) and information about vaccine administration (79%), as well as
information on how to effectively discuss HPV with their patients (86%). Almost 90% of
the participants reported that patients were most often referred to their primary care
providers for follow-up of medical conditions, and two-thirds of participants stated that
they knew where to refer their patients for HPV vaccination, however only a little more
than half (57%) knew where they could refer patients for HPV information.
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While 93% of participants agreed they were not only responsible for their
patients’ oral health, but also, patients’ overall health, less than half the respondents
(46%) agreed that HPV was within the scope of orthodontic practice. Moreover, although
64% of participants believed communication with patients and their parents about HPV is
important, none reported providing patients informational pamphlets or educational
videos regarding HPV and only 3% reported ever discussing HPV with patients and their
parents. Regarding future behaviors, 55% and 66% of respondents, respectively, were
unwilling to either discuss HPV with their patients or present an HPV informational
video. Yet, 68% of the respondents reported a willingness to offer HPV informational
pamphlets within the next year. Moreover, only 32% of participants considered it their
responsibility to personally deliver HPV educational intervention, and more than half
agreed delivering HPV educational interventions could be delegated to a chairside
assistant, or treatment coordinator/office manager, 53% and 52%, respectively. The
majority of respondents (64%) reported they would offer HPV educational intervention
regardless of third-party reimbursement and few participants (19%) expected
reimbursement in return for such a service; however, nearly three-fourths (74%) were
willing to devote only two minutes or less to providing an HPV educational intervention.

More than three-quarters of respondents (82%) agreed that they would feel that
they were acting in the patients’ best interest by providing HPV educational
interventions, however, only 40% reported that they would feel comfortable doing so.
Three-fourths of participants agreed that patients and their parents would be
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uncomfortable if they offered HPV educational intervention and more than half (52%)
were afraid that patients would be offended if they did. Similarly, only 31% respondents
agreed patients and their parents were amenable to HPV educational interventions in the
orthodontic setting. In addition, only 30% of participants agreed that their colleagues’
perception of them as orthodontists would improve and 36% agreed that their patients’
perception of them as orthodontists would improve if they offered HPV educational
intervention.

Notably, 81% of participants reported that it was important to vaccinate children
between the ages of 11 and 12 years for HPV, but 74% were not willing to deliver the
vaccine, even if administration of vaccines were considered to be within the scope of
dental practice. Similar to responses regarding discussing HPV with patients and parents,
72% of respondents felt if they offered the HPV vaccine they would be acting in their
patients’ best interest, only 26% agreed their colleagues’ perception of them as
orthodontists would improve and 27% agreed that their patients’ perception of them as
orthodontists would improve, if they did so. Finally, 62% of participants agreed that they
would be concerned about negative reactions from patients if they offered the HPV
vaccine.

3.3. Principle Component Analysis – Factor Loading
Table 2 presents the results of the principle component analysis (PCA). Factor
loading occurs when seemingly correlated observed variables (survey items) are
transformed into linear combinations of optimally weighted observed variables, creating
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principal components that independently account for the maximum amount of variance in
the data set not accounted for by previous components and are uncorrelated with other
components. According to Clark and Watson,49 meaningful principal components must
have three or more variables loading. In our study, seven components were identified and
six retained from the PCA. The six components described conceptual constructs of the
IBM that included, Perceived Norm (Injunctive Norm), Knowledge, Personal Agency
(Self-Efficacy and Perceived Control), Salience, and Environmental Constraints. One of
the seven identified components was uninterpretable and consequently not used. The
IBM constructs of Attitude and Habit were not identified as principal components within
our response data.

The variables that loaded on the component representing Injunctive Norm
examined respondents’ agreement that their colleagues’ and patients’ perception of them
would improve if they offered HPV educational intervention and the HPV vaccine,
agreement they would make patients and their parents uncomfortable if they discussed
HPV, and their willingness to discuss HPV with patients and parents. Self-rated
knowledge of HPV and the HPV vaccine, routine childhood vaccines and modes of
disease transmission, as well as agreement that additional knowledge regarding HPV
prevention is required, were variables which reflected the conceptual construct of
Knowledge. The Self-Efficacy construct was composed of variables that assessed whether
respondents knew where to refer patients for HPV information and vaccination. Variables
that loaded under Salience examined whether orthodontists were encouraged to discuss
HPV and recommend the vaccine to patients during their education, agreement they
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would be afraid of offending patients if they offered HPV educational intervention,
agreement they would be concerned about negative reactions from patients if they offered
the HPV vaccine, where they most often refer for follow-up of medical conditions, and
agreement that HPV educational intervention can be delegated to a treatment coordinator
or office manager. Importance of HPV communication, agreement that additional HPV
discussion skills and vaccination information are required, willingness to give an HPV
informational pamphlet, and agreement that orthodontists are responsible for overall
patient health were variables that loaded on the construct identified as Perceived Control.
Finally, variables that loaded on the IBM construct identified as Environmental
Constraints questioned whether participants learned about HPV during their professional
training, agreement that HPV is a preventable disease, reimbursement expectation for
HPV educational intervention, and agreement to provide educational intervention without
reimbursement.

3.4. Multivariable Logistic Regression
Multivariable logistic regression was used to examine the determinants of
orthodontists’ willingness to provide an HPV educational intervention (Table 3) and
orthodontists’ agreement that HPV is within the scope of orthodontic practice (Table 4)
by computing adjusted odds ratios (AOR). Model building began with those variables
forced into the model (sociodemographic and practice characteristic variables),
independent variables outlined in Specific Aims 2-4, the six constructs of the IBM
identified by the PCA, and all remaining covariates with a p-value ≤ 0.25. Model
building then proceeded with stepwise deletion of non-significant variables, resulting in
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the most parsimonious and explanatory model following method of Hosmer and
Lemeshow.46

3.4.1. Willingness to provide patients with an HPV educational intervention.
As presented in Specific Aims 2 and 3, we examined associations between Florida
Orthodontists’ self-rated knowledge and agreement that HPV is within the scope of
orthodontic practice, and their willingness to provide patients with an HPV educational
intervention. Neither self-rated knowledge nor agreement that HPV is within the scope of
orthodontic practice, were significant determinants of orthodontists’ willingness to
provide an HPV educational intervention. However, for each year that participants’ aged,
the adjusted odds of willingness increased 12% (AOR = 1.12, 95% CI 1.02, 1.23).
Additionally, for those participants who agreed that HPV causes cancer in females, they
were four times more willing to provide an HPV educational intervention than those who
disagreed that HPV causes cancer in females (AOR = 4.07, 95% CI 1.51, 10.94). Of the
six components identified from the PCA and included in the regression model, two were
statistically significant determinants of orthodontists’ willingness to provide an HPV
educational intervention to patients, namely, Perceived Control and Salience. After
controlling for Gender, Age, Race, Hispanic/Latino ethnicity, and other covariates, for
each 1-unit increase in Perceived Control, the odds of orthodontists’ willingness were
two times greater than their unwillingness to provide an HPV educational intervention
(AOR = 2.03, 95% CI 1.06, 3.90). In addition, orthodontists’ adjusted odds of willing vs.
unwilling to provide an HPV educational intervention was three times greater for every
1-unit increase in Salience (AOR = 3.09, 95% CI 1.35, 7.09), after controlling for
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sociodemographic variables and other covariates. However, Self-Efficacy (AOR = 5.40,
95% CI 0.94, 31.2), agreement that delivering educational intervention can be delegated
to a chairside assistant (AOR = 1.42, 95% CI 0.86, 2.34), and the amount of office time
respondents were willing to spend to provide an HPV educational intervention to their
patients (AOR = 9.72, 95% CI 0.72, 130.94), were not statistically significant
determinants of orthodontists’ willingness to provide an educational intervention.

3.4.2. Agreement that HPV is within the scope of orthodontic practice.
Specific Aim 4 examined the association between Florida Orthodontists’
encouragement to either discuss HPV with their patients and/or recommend the HPV
vaccine during their professional education and their agreement that HPV is within the
scope of orthodontic practice. Model building followed the methods used in Specific
Aims 2 and 3. After controlling for sociodemographic and practice characteristics, neither
of the primary independent variables of interest, namely, encouragement to discuss HPV
with their patients and/or recommend the HPV vaccine during their professional
education, were statistically significant determinants of Florida Orthodontists’ agreement
that HPV is within the scope of orthodontic practice. The only significant determinant of
participant orthodontists’ agreement that HPV is within the scope of orthodontic practice
was the amount of office time that respondents were willing to allocate to HPV
educational interventions within their practices. The more office time respondents could
provide to deliver HPV information to patients, the adjusted odds of agreement were
greater. For respondents willing to spend less than 1 minute providing HPV information,
the adjusted odds of agreement was over seven times greater than their disagreement
(AOR = 7.55, 95% CI 1.09, 52.33), for 1-2 minutes over twenty-one times greater (AOR
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= 21.20, 95% CI 3.44, 130.52), and for 3-4 minutes over forty-one times greater (AOR =
41.05, 95% CI 6.04, 279.12). Neither Perceived Control (AOR = 1.53, 95% CI 0.82,
2.85) nor Salience (AOR = 0.72, 95% CI 0.46, 1.13) were statistically significant
determinants of orthodontists’ agreement that HPV is within the scope of orthodontic
practice.
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Chapter 4: Discussion
HPV is the most common sexually transmitted virus and while most infections
resolve through normal immunogenic processes, HPV can cause a number of health
sequelae that range from benign warts to invasive cancers.1,2 HPV has been identified as
an etiologic agent for oropharyngeal cancers, making HPV particularly relevant to
dentists and dental specialists.5,6,9,31 While few long-term studies have considered the
efficacy of three FDA-approved vaccines in the prevention of oropharyngeal cancers,
current evidence is promising. One study examined the efficacy of Cervarix in 5,840
Costa Rican women as part of a double-blind controlled trial.50 Four years after
vaccination, there were fifteen prevalent oral HPV16/18 infections in the control group
and only one in the vaccine group, with an estimated vaccine efficacy of 93.3%.50
Despite such encouraging data, dentists and dental specialists remain surprisingly
underutilized in addressing the low HPV vaccination rates in this country.

In 2014, 83% of children aged 2-17 years, visited a dentist (including specialists
such as orthodontists) in the previous year.34 Because patients visit orthodontists
frequently and for prolonged periods, orthodontists have multiple, continuing
opportunities to offer patients and their parents important educational information
regarding HPV and the need to vaccinate, that has been previously overlooked.
Orthodontic specialists are particularly well positioned for this role given the majority of
their patients are within the target ages for the vaccine.26 According to the AAO, nearly
three-quarters of patients treated by orthodontists in 2014 were 17 years of age or
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younger.35,36 This is consistent with our findings that a majority of patients (72%) in the
practices of our study participants were 17 years of age or younger.

The role of dentists and dental specialists in the prevention of HPV-related
malignancies remains a subject of limited research.32,33 Few studies have examined
barriers or facilitators associated with provider-driven HPV educational intervention in
the dental setting and, to our knowledge, none in the orthodontic setting. One fact is
clear, despite the opportunities of frequent, long-term patient contact provided by
orthodontists to deliver an HPV educational intervention, our study revealed the
orthodontic venue is underutilized for this important and timely interaction between
orthodontists, patients and their parents. Daley et al.,32 found that more than 52% of
Florida dentists reported no intention to discuss the HPV vaccine with their female
patients. Daley et al.,32 concluded that lack of intent was due to discomfort discussing
sexual health related topics, absence of guidelines or oversight from dental professional
organizations, and an interaction viewed as outside the scope of dental practice. Such
findings are consistent with our study that indicated the majority of participant
orthodontists were uncomfortable discussing HPV with patients and their parents and if
they did so, were afraid they would offend their patients. In spite of expressed concern of
parents’ reactions by our participants, there is evidence that suggests that parents would
not only be amenable to the receipt of HPV information in the orthodontic care setting,
but also, willing to allow their children to receive the HPV vaccination, if only the
orthodontist would recommend vaccination.33 Shapiro33 examined parents’ willingness to
allow their child to receive the HPV vaccine and reported that the strongest predictor of
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parents’ willingness to receive the HPV vaccine was if parents considered vaccination
salient. Shapiro33 found that a critical factor contributing to parents’ perception of
salience was receipt of a recommendation to vaccinate from an orthodontist. This
suggests that orthodontists are important parental influencers with respect to overall
health and furthermore, that a recommendation from an orthodontist regarding HPV
immunization predicts a parent’s decision to vaccinate.33 Apparently, orthodontists’
influence over their patients’ health behaviors is greater than orthodontists realize.
Shapiro’s33 findings suggest that orthodontists may have a critical impact on parents’
willingness to allow their children to receive the HPV vaccine. Perhaps, dissemination of
Shapiro’s findings could positively influence orthodontists and orthodontic leadership of
this important missed opportunity to positively impact patient health.

Our study is among the first to assess orthodontists’ attitudes and beliefs
regarding HPV educational intervention in the orthodontic care setting. We examined
participant orthodontists’ agreement that HPV is within the scope of orthodontic practice
and their willingness to provide an HPV educational intervention to patients.
Furthermore, our study sought to identify barriers or facilitators associated with offering
an HPV educational intervention, and to understand what mode of intervention
orthodontists’ would be willing to deliver.

We hypothesized that orthodontists’ agreement that HPV was within the scope of
orthodontic practice would increase with encouragement during professional education to
either discuss HPV with, or recommend the HPV vaccine to their patients. Neither
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encouragement to discuss HPV nor recommend the HPV vaccine during professional
education were significant determinants of orthodontists’ agreement that HPV was within
the scope of orthodontic practice. In fact, 54% of our participants disagreed that HPV is
within the scope of orthodontic practice, similar to Daley et al.,32 who found that Florida
dentists responded that HPV was not within the scope of dental practice. However, the
amount of office time respondents would be willing to provide to deliver HPV
information to patients was a significant predictor of agreement that HPV was within the
scope of orthodontic practice (AOR = 2.13, 95% CI 1.17, 3.86). Indeed, 70% of
participant orthodontists in our study reported they could provide some amount of office
time to deliver HPV information. It is not difficult to infer that the more time respondents
were willing to dedicate to the delivery of HPV information, the more likely they were to
agree that HPV was within the scope of orthodontic practice. Our participants
overwhelmingly reported a need for additional knowledge regarding skills for effectively
communicating about HPV and HPV prevention with patients and their parents. Perhaps
this highlights an opportunity for the AAO to provide proactive guidance that could
support orthodontists’ need for knowledge and promote an understanding that HPV is
within their purview.

We also hypothesized that orthodontists’ willingness to provide patients with an
HPV educational intervention would increase with greater self-rated knowledge of HPV
and the HPV vaccine and with agreement that HPV is within the scope of orthodontic
practice. Neither self-rated knowledge nor agreement that HPV is within the scope of
orthodontic practice, were significant determinants of orthodontists’ willingness to
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provide an HPV educational intervention. These findings also are consistent with those of
Daley et al.,32 in that HPV-related knowledge was also not a predictor of dentists’
readiness to discuss HPV with their patients. However, agreement that HPV causes
cancer in females was a significant predictor of willingness to provide an HPV
educational intervention in our study, suggesting a rudimentary understanding of the
virus does indeed play a role in willingness. To help understand this inconsistency, it is
important to note that the majority of our sample (73%) completed their postgraduate
orthodontic residency programs before 2010, the year the American Dental Association
(ADA) acknowledged HPV as a risk factor for oropharyngeal cancers.51 Furthermore, it
was only in 2006 that one of the largest U.S. pharmaceutical companies, Merck and
Company, obtained approval for the first HPV vaccine.18 Therefore, it is possible that
many of our participants are unfamiliar with the most current scientific evidence
pertaining to virus sequelae and the strain-specific vaccines that prevent HPV infections.
Perhaps this unfamiliarity minimized the role of self-rated knowledge in participants’
willingness to provide an HPV educational intervention. In fact, two studies have
assessed dentists’ knowledge regarding HPV and its relationship to oropharyngeal
cancers.52,53 Daley et al.,52 reported deficits in dental professionals’ knowledge of the
pathogenesis of HPV and the impact of HPV on overall health. Vázquez-Otero et al.,53
found confusion among dentists regarding differences between low and high risk strains
of the HPV virus and the implications in the development of certain cancers.53 Data
suggests dentists may need additional knowledge to provide patients with the most up-todate information regarding HPV and the HPV vaccine.52,53 Consistent with these
findings, participant orthodontists in our study reported a need for additional knowledge
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regarding HPV prevention (86%). This not only highlights the importance of professional
school education in preparing clinicians to effectively discuss HPV and the HPV vaccine
with patients and their parents, but also of continuing education and a professional’s role
and responsibility to be a life-long learner and seeker of knowledge.

We found that Perceived Control and Salience, were significant determinants of
orthodontists’ willingness to provide an HPV educational intervention. The IBM
construct, Perceived Control, was composed of survey items assessing agreement that in
order for our participants to contribute to a public health effort aimed at increasing HPV
vaccination rates among their adolescent patients, additional information about discussing
HPV effectively (79%) and about vaccine administration (86%) were needed. Clearly,
our respondents perceived that they lacked sufficient skills to effectively communicate
with their patients about HPV and the HPV vaccine. It may be that these insecurities
result from most respondents (89%) report of a lack of encouragement to either discuss
HPV or the HPV vaccine during their education. Furthermore, such insecurities may be
the reason that more than half of our participants (55%) were unwilling to have a direct
conversation with patients and their parents regarding HPV. Encouragingly, 68% of
respondents reported a willingness to provide patients with an HPV informational
pamphlet within the next 12-months. These findings suggest an obvious opportunity for
the AAO to support orthodontists in impacting HPV vaccination rates among their
patients by development and provision of educational pamphlets. It may be that such
pamphlets are a reasonable solution to the dichotomy between perceived insufficient
skills, reluctance to have direct conversations, and the importance of HPV.
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Salience was one of the most impactful determinants of participants’ willingness
to provide an HPV educational intervention. Variables that loaded on the construct of
Salience included encouragement to discuss HPV or recommend the vaccine during
professional education. Our findings suggest that few participants were encouraged to
discuss HPV or recommend the vaccine during professional education. Promisingly,
Poelman et al.,54 found that current pre-doctoral and post-doctoral students placed value
in HPV vaccine discussions with patients and desired more education in oral cancer
detection. Such findings are corroborated by a recent editorial entitled “Could Your Next
Doctor Be Your Dentist”, by Nisarg Patel,55 a senior Harvard Dental School student.
Patel55 suggested a broader scope of dental practice that includes preventive primary
healthcare to address the shortage of affordable healthcare in the United States. To
accomplish this, Patel55 explained that more dental schools need to adopt a
comprehensive medical education model. Encouragement to discuss HPV and
recommend the HPV vaccine during dental education may provide a first step in
beginning to change orthodontist’s attitudes about the appropriateness of discussing HPV
and habituate orthodontists to such discussions with patients.

The majority of participant orthodontists reported the importance of
communication with patients and parents about HPV despite their unwillingness to do so.
Perhaps the time is ripe for orthodontists to exercise their professional responsibilities
and act on their beliefs related to overall patient health and the importance of childhood
vaccinations and communication about HPV. Indeed, orthodontists have a unique
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opportunity with repeated long-term contact with adolescents, the population most at risk
to HPV. Adolescents are also the target age group for the HPV vaccine. As such,
orthodontists are in the driver’s seat of what may be considered the “ground zero” venue
for delivering effective HPV prevention efforts. Mobilizing orthodontists in such efforts
requires a collaborative approach, emphasizing their unique position in healthcare. It
seems reasonable to suggest that the AAO may play a pivotal role given that both the
ADA and the ADA Council on Scientific Affairs encourage dentists to educate
themselves and their patients about the relationship between HPV and oropharyngeal
cancer.56 After all, Daley et al.,32 found that dentists seek approval and guidance from
their professional organizations. Orthodontists may turn to the AAO for support and
guidelines in fulfilling their reported responsibility to overall patient health, and in doing
so, aid in the development of effective means to implement educational interventions in
the orthodontic practice setting.

Because Salience was a statistically significant predictor of orthodontists’
willingness to provide an HPV educational intervention in our study, a paradigm shift is
necessary, whereby the importance of orthodontists’ role in the prevention of HPV is
communicated by the AAO to its member orthodontists. As health professionals,
orthodontists can no longer sit idly by and accept the rising incidence of HPV-related
cancers as anything other than preventable. Our study reveals specific opportunities for
orthodontists’ to fulfill their self-reported obligation to overall patient health, by
contributing to a necessary public health effort to increase the low HPV vaccination rates
in this country. It is time for orthodontists, with the support of their professional
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organizations and the institutions that educate them, to mobilize and collectively halt the
spread of HPV infections.
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Chapter 5: Conclusions
Orthodontists have an ethical responsibility to address low HPV vaccination rates,
a critical public health issue. However, a clear disconnect exists between how
respondents view their roles and responsibilities as healthcare providers, and their
actions. This disparity highlights the need for targeted interventions to mobilize
orthodontists to fulfill their self-reported obligation to overall patient health. Our findings
suggest an opportunity to impact orthodontists’ willingness to provide an HPV
educational intervention by encouraging and preparing clinicians to discuss HPV and the
HPV vaccine effectively in professional school and continuing education, the availability
and dissemination of informational pamphlets, and support and guidance from the
American Association of Orthodontists (AAO). Such support and guidance from the
AAO is necessary to promote orthodontists’ understanding that HPV is within the scope
of orthodontic practice. This study provides a foundation for future public health efforts
aimed at addressing low HPV vaccination rates by outlining approaches to mobilize a
potentially potent, but previously overlooked, venue for HPV prevention.

5.1. Strengths and Limitations
A strength of our study is that it is among the first to examine orthodontists’
willingness to provide an HPV educational intervention by representative sampling of
Florida Orthodontists. Moreover, our study was informed by the Integrated Behavior
Model (IBM); a valid measurement of behavioral intent appropriate to our specific aims.
Our study was further strengthened by use of focus group elicitations that identified
beliefs of our sample population in order to permit accurate measurement of IBM
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constructs within our survey instrument.37 The low survey response rate (25.4%) was a
limitation of this study despite fidelity to accepted methods of survey administration.
Given that only a quarter of our sample responded, the threat to validity is that there may
be systematic differences between respondents and non-respondents, and as such, our
results may not be representative of the population studied. In fact, the low response rate
may be an important finding in itself, as an indicator of the magnitude of effort required
to communicate the importance of HPV vaccination to orthodontists. Nonetheless, the
findings of this study will help inform future public health interventions using a potent,
yet underutilized, healthcare venue targeted towards increasing orthodontic patients’ and
their parents’ awareness and knowledge of HPV and the HPV vaccines with the intent of
increasing HPV vaccination rates among adolescents.

5.2. Future Studies
Because so little has been published regarding the role of the dental profession,
and orthodontists in particular, in positively contributing to an increase in HPV
vaccination rates among adolescents, there are many topic areas for future research. For
example, future research may examine the impact of HPV educational intervention (i.e.,
delivering informational pamphlets) on HPV vaccination rates in the orthodontic care
setting. Furthermore, there is need to examine the association between official guidelines
released by the AAO regarding HPV, and prevalence of orthodontists providing HPV
information to their patients, whether the current mode of information dissemination is
effective, or if there may be more effective means to disseminate such information.
Future research may also evaluate the impact of a pilot pre-doctoral dental curriculum
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that emphasizes the impact of oral health on overall systemic health, and focuses on HPV
by pinpointing the development of doctor-patient communication skills beyond the
academic setting. In addition, there is a need to gather information from dental school and
orthodontic residency administrators regarding their willingness to include HPV in
respective curricula, and to provide a directive for them to do so. An opportunity exists to
contribute to public health efforts to increase HPV vaccination rates and decrease HPVrelated oropharyngeal cancers; an opportunity that must not be missed through targeted
public health interventions informed by future studies.
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Table 1. Characteristics of orthodontist participants currently practicing in the state of Florida (N=119), 2017
Willing to Provide HPV
Educational Intervention

Overall

Agree HPV is Within the Scope
of Orthodontic Practice

Characteristic

Gender
Female

Frequency
(Mean)

Percent
(SE)

Column %
[Mean (SE)]

P-Value

Column %
[Mean (SE)]

P-Value

0.81

15.5

0.53

< 0.01

30.2
[48.6 (48.9)]

< 0.01

43

36.75

25.6

Male
Age (years)
Race
White
Black or African American
Asian
Other
Hispanic / Latino
No
Yes
Graduation Year

74
(48.64)

63.25
(1.19)

42.7
[48.6 (49.7)]

100
4
5
8

85.47
3.42
4.27
6.84

59.0
1.7
2.6
6.0

0.54

38.8
1.7
1.7
3.5

0.98

99
19

83.9
16.1

55.9
12.7

0.29

37.6
7.7

0.84

< 1970
1970 - 1979
1980 - 1989
1990 - 1999
2000 - 2010
> 2010
Years in Practice
Patients treated daily
0-25
26-50
51-75
76-100
100+
Patients
≤ 17 years of age
≥ 18 years of age

1
11
20
22
32
31
(18.01)

0.85
9.4
17.09
18.8
27.35
26.5
(1.23)

0.9
6.8
13.7
12.0
18.0
18.0
[18.0 (18.8)]

0.83

0.9
4.3
6.0
9.5
12.9
12.1
[17.9 (17.8)]

0.85

20
35
42
15
3

17.39
30.43
36.52
13.04
2.61

13.9
20.9
27.8
3.5
2.6

< 0.01

11.4
14.9
14.9
2.6
1.8

0.11

(72.06)
(28.47)

(1.25)
(1.36)

[72.1 (71.2)]
[28.5 (28.7)]

< 0.01

[72.0 (70.8)]
[28.5 (29.3)]

< 0.01
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< 0.01

< 0.01

Table 1 (Continued)
Willing to Provide HPV
Educational Intervention

Overall
Characteristic

Practice Setting
Private practice
University-based practice
Public Health practice
Practice Type
Solo practice
Group practice
Practice Location
Urban
Rural
HPV content during education
Received instruction
No
Yes
Encouraged to discuss/recommend vaccine
No
Yes
HPV knowledge
Self-rated knowledge
None/limited
Moderate
Good
Excellent
Causes cancer in females
Disagree
Agree
Causes cancer in males
Disagree
Agree
Knowledge of disease transmission modes
None/limited
Moderate
Good
Excellent

Agree HPV is Within the Scope
of Orthodontic Practice

Frequency
(Mean)

Percent
(SE)

Column %
[Mean (SE)]

112
4
1

95.73
3.42
0.85

64.1
3.4
0.9

0.30

41.4
3.5
0.9

0.04

87
30

74.36
25.64

48.7
19.7

0.26

34.5
11.2

0.76

106
9

92.17
7.83

64.4
4.4

0.38

41.7
3.5

0.96

38
81

31.93
68.07

24.4
44.5

0.23

15.3
30.5

0.67

106
13

89.08
10.92

58.8
10.1

0.05

39.8
5.9

0.54

12
67
31
7

10.26
57.26
26.5
5.98

6.0
40.2
18.0
5.1

0.65

4.3
25.9
12.9
3.5

0.92

6
112

5.08
94.92

2.5
66.1

0.31

1.7
43.6

0.55

24
94

20.34
79.66

11.0
57.6

0.09

6.0
39.3

0.07

12
58
38
11

10.08
48.74
31.93
9.24

8.4
31.1
21.9
7.6

0.43

3.4
22.0
16.1
4.2

0.77
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P-Value

Column %
[Mean (SE)]

P-Value

Table 1 (Continued)
Willing to Provide HPV
Educational Intervention

Overall
Characteristic

Sexually transmitted disease
Disagree
Agree
Preventable disease
Disagree
Agree
Self-rated knowledge of HPV vaccine
None/Limited
Moderate
Good
Excellent
Self-rated knowledge of HPV vaccine
None/limited
Moderate
Good
Excellent
Self-assessment regarding HPV-related
material
Additional knowledge needed about HPV
prevention
Disagree
Agree
Information on discussion skills needed
Disagree
Agree
Information on vaccination administration
needed
Disagree
Agree
Patient referrals
Know where to refer for HPV information
No
Yes

Agree HPV is Within the Scope
of Orthodontic Practice

Frequency
(Mean)

Percent
(SE)

Column %
[Mean (SE)]

8
109

6.84
93.16

6.8
61.5

0.05

4.3
40.5

0.30

3
114

2.56
97.44

0.9
67.5

0.19

1.7
43.1

0.44

14
51
41
13

11.76
42.86
34.45
10.92

9.2
26.9
24.4
8.4

0.58

5.1
20.3
14.4
5.9

0.76

32
63
21
3

26.89
52.94
17.65
2.52

17.7
39.5
10.1
1.7

0.48

11.9
26.3
5.9
1.7

0.51

17
101

14.41
85.59

5.9
63.6

0.01

5.1
41.0

0.33

16
101

13.68
86.32

4.3
65.8

< 0.01

2.6
44.0

0.02

25
92

21.37
78.63

10.3
58.1

0.01

8.6
37.1

0.52

51
68

42.86
57.14

32.8
36.1

0.12

19.5
26.3

0.96
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P-Value

Column %
[Mean (SE)]

P-Value

Table 1 (Continued)
Willing to Provide HPV
Educational Intervention

Overall
Characteristic

Know where to refer for HPV vaccination
No
Yes
Don't know where to refer for HPV vaccine
Disagree
Agree
Medical referrals
Physician's in my own referral network
Refer patients to their primary care provider
I do not usually refer for medical conditions
Other
Orthodontists responsible for patient health
Disagree
Agree
HPV is within the scope of practice
Disagree
Agree
HPV information currently provided
Discussion
No
Yes
Informational pamphlets
No
Educational video
No
Willing to discuss HPV with patients/parents
Not willing
Willing
Willing to offer HPV informational pamphlet
Not willing
Willing
Willing to offer HPV educational video
Not willing
Willing

Agree HPV is Within the Scope
of Orthodontic Practice

Frequency
(Mean)

Percent
(SE)

Column %
[Mean (SE)]

40
79

33.61
66.39

25.2
43.7

0.31

15.3
30.5

0.95

84
34

71.19
28.81

47.5
21.2

0.47

33.3
12.0

0.70

1
107
9
2

0.84
89.92
7.56
1.68

0.0
63.9
5.0
0.0

0.08

0.0
44.1
1.7
0.0

0.17

8
111

6.72
93.28

1.7
67.2

0.01

0.9
44.9

0.05

64
54

54.24
45.76

28.0
40.7

< 0.01

114
4

96.61
3.39

66.1
3.4

0.18

42.7
3.4

0.03

119

100

68.9

45.8

118

100

69.5

46.2

65
54

54.62
45.38

23.5
45.4

< 0.01

11.0
34.8

< 0.01

38
81

31.93
68.07

0.8
68.1

< 0.01

5.1
40.7

< 0.01

79
40

66.39
33.61

35.3
33.6

< 0.01

20.3
25.4

< 0.01
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P-Value

Column %
[Mean (SE)]

P-Value

Table 1 (Continued)
Willing to Provide HPV
Educational Intervention

Overall
Characteristic

Willingness to offer an educational
intervention (discussion, pamphlets, video)
Not willing
Willing
Importance of HPV communication
Unimportant
Important
Orthodontists’ comfort discussing HPV
Disagree
Agree
Colleagues' perception of orthodontist
improved
Disagree
Agree
Acting in best interest of patient
Disagree
Agree
Patients/parents amenable to HPV
information
Disagree
Agree
Patients' perception of orthodontist would
improve
Disagree
Agree
Patients/parents would be uncomfortable
discussing HPV
Disagree
Agree
Afraid of offending patients
Disagree
Agree

Frequency
(Mean)

Percent
(SE)

Column %
[Mean (SE)]

37
82

31.09
68.91

42
76

35.59
64.41

17.0
51.7

71
47

60.17
39.83

83
35

Agree HPV is Within the Scope
of Orthodontic Practice

P-Value

Column %
[Mean (SE)]

P-Value

5.1
40.7

< 0.01

< 0.01

6.0
39.3

< 0.01

35.6
33.1

0.01

16.2
29.1

< 0.01

70.34
29.66

42.4
26.3

< 0.01

23.9
21.4

< 0.01

21
98

17.65
82.35

5.9
63.0

< 0.01

2.5
43.2

< 0.01

79
36

68.7
31.3

41.7
27.0

0.01

21.1
23.7

< 0.01

76
42

64.41
35.59

36.4
32.2

< 0.01

18.0
27.4

< 0.01

29
87

25
75

23.3
45.7

< 0.01

21.7
23.5

< 0.01

57
61

48.31
51.69

37.3
31.4

0.05

29.1
16.2

< 0.01
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Table 1 (Continued)
Willing to Provide HPV
Educational Intervention

Overall
Characteristic

Providing HPV information
Is orthodontist's responsibility
Disagree
Agree
May be delegated to chairside assistant
Disagree
Agree
May be delegated to treatment
coordinator/office manager
Disagree
Agree
Time willing to spend providing HPV
information
Not willing
Less than 1 minute
1-2 minutes
3-4 minutes
5 minutes or more
Orthodontists’ responses about HPV vaccine
Vaccination of children at 11-12 years old
Unimportant
Important
Willing to deliver HPV vaccine to patients*
Not willing
Willing
Colleagues' perception of orthodontist
improved
Disagree
Agree
Patients' perception of orthodontist
improved
Disagree
Agree

Agree HPV is Within the Scope
of Orthodontic Practice

Frequency
(Mean)

Percent
(SE)

Column %
[Mean (SE)]

80
37

68.38
31.62

41.9
26.5

0.01

21.6
23.3

< 0.01

55
61

47.41
52.59

28.5
39.7

0.08

20.0
24.4

0.60

56
60

48.28
51.72

27.6
40.5

0.01

18.3
26.1

0.20

35
22
29
22
9

29.91
18.8
24.79
18.8
7.69

7.7
13.7
22.2
17.1
7.7

< 0.01

3.5
6.0
13.8
14.7
6.9

< 0.01

22
96

18.64
81.36

9.3
60.2

0.03

4.3
41.9

0.01

88
31

73.95
26.05

46.2
22.7

0.01

29.7
16.1

0.03

86
30

74.14
25.86

45.7
22.4

0.01

25.2
19.1

< 0.01

83
31

72.81
27.19

43.0
25.4

< 0.01

23.9
20.4

< 0.01
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P-Value

Column %
[Mean (SE)]

P-Value

Table 1 (Continued)
Willing to Provide HPV
Educational Intervention

Overall
Characteristic

Acting in best interest of patient
Disagree
Agree
Negative reactions from patients
Disagree
Agree
Acting in best interest of patient
Disagree
Agree
Expect reimbursement for educational
intervention
Disagree
Agree
Would provide educational intervention
without reimbursement
Disagree
Agree
Survey response by:
Hard Copy Survey response
Web-based Survey Response
Integrated Behavior Model (IBM) Constructs
Perceived Norm (Injunctive Norm)
Self-Rated Knowledge
Personal Agency (Self-Efficacy)
Salience
Personal Agency (Perceived Control)
Environmental Constraints

Agree HPV is Within the Scope
of Orthodontic Practice

Frequency
(Mean)

Percent
(SE)

Column %
[Mean (SE)]

33
83

28.45
71.55

15.5
52.6

0.05

6.1
38.3

< 0.01

44
71

38.26
61.74

30.4
37.4

0.03

21.9
21.9

0.03

33
83

28.45
71.55

15.5
52.6

0.05

6.1
38.3

< 0.01

96
23

80.67
19.33

56.3
12.6

0.67

38.1
7.6

0.48

42
76

35.59
64.41

18.6
50.9

< 0.01

9.4
36.8

< 0.01

76
43

63.87
36.13

42.9
26.1

0.57

25.4
20.3

0.07

0.00
0.00
0.00
0.00
0.00
0.00

0.19
0.16
0.15
0.13
0.14
0.13

[0.58, (0.24)]
[-0.02, (0.19)]
[-0.11, (0.18)]
[-0.16, (0.16)]
[0.62, (0.09)]
[0.25, (0.15)]

<0.01
1.0
0.27
0.03
<0.01
0.01

[1.18, (0.32)]
[0.03, (0.23)]
[0.05, (0.21)]
[-0.39, (0.18)]
[0.58, (0.13)]
[0.44, (0.18)]

<0.01
0.47
0.91
0.01
<0.01
0.01

[

Column %
[Mean (SE)]

P-Value

This item was prefaced by the hypothetical: “If administration of vaccines were considered within the scope of dental practice…”
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P-Value
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Table 2 – Principal Component Analysis (N=119)
Components
Variables
Colleagues' perception of orthodontist improved (HPV)
Colleagues' perception of orthodontist improved (vaccine)
Discuss HPV with patients/parents (willing)
Patients' perception of orthodontist improved (vaccine)
Patients' perception of orthodontist improved (HPV)
Patients/parents uncomfortable discussing HPV
Self-rated knowledge of routine childhood vaccines
Self-rated knowledge of HPV vaccine
Additional knowledge required
Modes of disease transmission
Self-rated knowledge (HPV)
Where to refer for HPV information
Where to refer for HPV vaccination
Don't know where to refer for HPV vaccine
Encouraged to discuss/recommend vaccine
Afraid of offending patients
Negative reactions from patients (vaccine)
Medical referrals
May be Delegated to treatment coordinator/office manager
(HPV)
Importance of HPV communication
Additional discussion skills required (HPV)
Additional vaccination information required
Willing to give HPV informational pamphlet
Orthodontists responsible for patient health
Received instruction
Preventable disease
Expect reimbursement for educational intervention
Would provide educational intervention without reimbursement
* A subcategory of Perceived Norm
† A subcategory of Personal Agency

Injunctive
Norm*

Self-rated
Knowledge

Self†
Efficacy

Salience

Perceived
†
Control

Environmental
Constraints

0.28
0.28
0.25
0.30
0.30
-0.27
0.30
0.32
-0.28
0.37
0.34
-0.43
-0.42
0.36
0.37
0.31
0.33
0.35
-0.25
0.27
0.28
0.26
0.27
0.25
0.26
0.28
0.47
-0.37
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Table 3 – Logistic regression results for the dependent variable “Willing to provide HPV educational
intervention” (N=119), 2017
Willing vs. unwilling to provide HPV educational
intervention
Model
Effect
AORa (95% CI)
p-value
p-value
Gender
Female
Male
Age
Race
White
Black or African American
Asian
Other
Hispanic / Latino
No
Yes
Practice Location
Urban
Rural
Practice Type
Solo practice
Group practice
Time willing to spend providing HPV
information
Not willing
Less than 1 minute
1-2 minutes
3-4 minutes
5 minutes or more
Providing HPV information may be delegated
to chairside assistant
Disagree
Agree
HPV causes cancer in females
Disagree
Agree
Personal Agency
Perceived Control
Self-Efficacy
Salience

0.111

0.021
0.287

1.00
4.29 (0.72, 25.71)
1.12 (1.02, 1.23)

…
0.111
0.021

1.00
1.07 (0.06, 18.09)
0.30 (0.027, 3.29)
0.21 (0.01, 8.34)

…
0.960
0.322
0.406

1.00
4.84 (0.11, 210.78)

…
0.413

1.00
2.52 (0.39, 16.19)

…
0.329

1.00
2.26 (0.23, 21.91)

…
0.481

1.00
131.40 (6.66, 2592.76)
371.81 (6.28, 22011.95)
175.57 (6.86, 4495.87)
…

…
0.001
0.004
0.002
…

1.00
1.42 (0.86, 2.34)

…
0.172

1.00
4.07 (1.51, 10.94)

…
0.005

2.03 (1.06, 3.90)
5.40 (0.94, 31.16)
3.09 (1.35, 7.09)

0.033
0.059
0.008

0.413

0.329

0.481

0.087

0.172

0.005

0.033
0.059
0.008

a. AOR – Adjusted Odds Ratio
b. Sociodemographic variables forced into the model as covariates: Gender, Age, Race, Hispanic/Latino, Practice
Location, and Practice Type
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Table 4 – Logistic regression results for the dependent variable “HPV is Within Scope of
Orthodontic Practice” (N=119), 2017
Agree vs. disagree that HPV is Within Scope of
Orthodontic Practice
Model
Effect
AORa (95% CI)
p-value
p-value
Gender
Female
Male
Age
Race
White
Black or African American
Asian
Other
Hispanic / Latino
No
Yes
Practice Location
Urban
Rural
Practice Type
Solo practice
Group practice
Time willing to spend providing HPV
information
Not willing
Less than 1 minute
1-2 minutes
3-4 minutes
5 minutes or more
Personal Agency
Perceived Control
Salience

0.242
0.114
0.464

1.00
0.49 (0.15, 1.63)
0.96 (0.92, 1.01)

…
0.242
0.114

1.00
0.53 (0.06, 4.42)
1.60 (0.09, 29.48)
0.41 (0.05, 3.69)

…
0.554
0.751
0.423

1.00
0.77 (0.14, 4.22)

…
0.764

1.00
3.82 (0.53, 27.38)

…
0.183

1.00
0.50 (0.14, 1.78)

…
0.286

1.00
7.55 (1.09, 52.33)
21.20 (3.44, 130.52)
41.05 (6.04, 279.12)
18.92 (0.95, 378.13)

…
0.041
0.001
0.000
0.054

1.53 (0.82, 2.85)
0.72 (0.46, 1.13)

0.182
0.151

0.764
0.183
0.286

0.013

0.182
0.151

a. AOR – Adjusted Odds Ratio
b. Sociodemographic variables forced into the model as covariates: Gender, Age, Race, Hispanic/Latino,
Practice Location, Practice Type
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FOCUS GROUP QUESTIONS
Experiential Attitude
How do you feel about the idea of providing HPV educational intervention to your patients
and their parents?
What do you like/dislike about the idea of providing HPV educational intervention to your
patients and their parents?
What would you enjoy/hate about providing HPV educational intervention to your patients
and their parents?
Instrumental Attitude
What are some of the advantages of providing HPV educational intervention to your
patients and their parents?
What are some of the benefits that might result from providing HPV educational
intervention to your patients and their parents?
What are some of the disadvantages of providing HPV educational intervention to your
patients and their parents?
What are the negative effects that might result from providing HPV educational intervention
to your patients and their parents?
Normative Influence
Who would support your decision to provide HPV educational intervention to your patients
and their parents?
Who would be against your decision to provide HPV educational intervention to your
patients and their parents?
If you were to consider providing an HPV educational intervention for your patients and
their parents, is there someone who’s opinion would be instrumental to you in your
decision?
Perceived Control
What things would make it easy for you to provide HPV educational intervention to your
patients and their parents?
What things would make it hard for you to provide educational intervention to your
patients and their parents?
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Self-Efficacy
If you want to provide HPV educational intervention to your patients and their parents, how
certain are you that you can?
What kinds of things would help you overcome any barriers to providing HPV educational
intervention to your patients and their parents?
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Participation Letter
Title of Study: Florida Orthodontists' willingness to provide Human Papilloma Virus
(HPV) Educational Intervention
Principal investigator
Marc Weber, D.D.S.
901 SE 2nd Court #2
Fort Lauderdale, FL 33301
(704) 491-8918

Co-investigator
Richard Singer, D.M.D., M.S.
3301 College Avenue
Fort Lauderdale, FL 33314
(954) 262-1610

For questions/concerns about your research rights, contact:
Human Research Oversight Board (Institutional Review Board or IRB)
Nova Southeastern University
(954) 262-5369 / Toll Free: 866-499-0790
IRB@nsu.nova.edu
Description of Study: You are invited to participate in a research study. The purpose of
this study will focus on identifying the determinants of Florida Orthodontists’ willingness
to provide information regarding the Human Papilloma Virus (HPV) and/or HPV
vaccinations to adolescent patients and their parents.
We are inviting you to participate because you are an orthodontist currently practicing in
the state of Florida. Participants include American Association of Orthodontists (AAO)
members recruited from the AAO member directory and non-AAO member orthodontists
recruited from the Florida Yellow Pages. The results of this study may be used to inform
possible future public health interventions aimed towards increasing acceptance of the
HPV vaccination and thereby reducing the prevalence of both HPV infections and
associated cancers. There will be between 400 to 450 participants in this research study.
You are asked to complete a self-administered 10 to 15-minute electronic survey housed
on the secure, HIPAA-compliant NSU REDCap web site. The survey includes multiple
choice and fill in the blank (drop-down list) items, including demographic information.
After you complete the survey instrument, your responses will be de-identified and
analyzed.
Risks/Benefits to the Participant: There is minimal risk to you as a participant. The
greatest potential risk may be compromised confidentiality and anonymity. However,
every reasonable attempt has been designed into the study administration protocols to
protect your confidentiality and anonymity, including use of a secure HIPAA-complaint
server for data acquisition and storage. If you have any questions about the research, your
research rights, or have a research-related injury, please contact Dr. Marc Weber or Dr.
Richard Singer at the phone numbers indicated above. You may also contact the IRB at
the numbers indicated above with questions as to your research rights. There are no direct
benefits for your participation in this study.
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Cost and Payments to the Participant: There are no costs to you and no monetary
compensation for participating in this study, however, participants who complete
the survey will be provided entry into a drawing for an Apple iWatch in appreciation
of their time and contribution to our research.
Confidentiality: All information obtained in this study is strictly confidential, unless
disclosure is required by law. Data collected using the secured web site, REDCap,
will be automatically de-identified to ensure anonymity and confidentiality of
participants. All participant email addresses and contact information will be
disassociated from survey response data and stored on a separate password
protected university server. All data acquired during this research will be deleted
after 36 months from the conclusion of the study as required by the IRB. The IRB,
regulatory agencies, and Dr. Weber or Dr. Singer may review research records.
Participant’s Right to Withdraw from the Study: Your participation is voluntary;
you are free to refuse to participate in or withdraw from this study at any time
without penalty. If you do not want to continue, you can simply leave this website. If
you do not click on the submit button at the end of the survey, your answers and
participation will not be recorded. If you choose to withdraw after completion of the
survey, any information collected from you before the date you leave the study will
be kept in the research records for 36 months from the conclusion of the study, but
you may request that it not be used by contacting the principal investigator in a
timely manner.
I have read this letter and I fully understand the contents of this document and
voluntarily consent to participate. All of my questions concerning this
research have been answered. If I have any questions in the future about this
study, the investigator listed above or his staff will answer them.
I understand that the completion of this questionnaire implies my consent to
participate in this study.
I have read and understand the informed consent above: YES
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HPV SURVEY INSTRUMENT
1. Study ID
2. I understand that the completion of this questionnaire implies my consent to
participate in this study.
I understand
3. Do you currently offer any of the following Human Papilloma Virus (HPV)
educational interventions to your patients?

1Yes

0No

a

HPV informational pamphlets
Discuss HPV with parents/patients
c HPV educational video
b

4. If you do not currently offer these interventions, how willing would you be to
offer it as part of your practice within the next year?
Willingness to Offer
0 not willing
a

1 somewhat unwilling

2 somewhat willing

3 very willing

HPV informational pamphlets
Discuss HPV with
parents/patients
HPV educational video

b
c

5. If administration of vaccinations were considered to be within the scope of dental
practice…

Willingness to Administer the HPV vaccine
0 not willing
a

How willing would you be to deliver the
HPV vaccine to your patients?
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1 somewhat
unwilling

2 somewhat
willing

3 very willing

6. The following concern HPV knowledge acquired during your professional
education.
1 Yes

0 No

a

Did you learn about HPV during your professional education?
b Were you encouraged to discuss HPV with your patients during your
professional education?
c Were you encouraged to recommend the HPV vaccine during your
professional education?

7. How would you rate your clinical knowledge of the following?
0

1 moderate

none/limited

2

good

3

excellent

a

Human Papilloma Virus (HPV)
HPV vaccinations (efficacy,
associated risks, availability)
c HPV modes of transmission
d Routine childhood vaccines (eg.,
MMR, DTaP, Polio)
b

8. Where is the one place where you most often refer patients for follow-up of
medical conditions? (please select one response)
Physician’s in my own referral network
Refer patients back to their own primary care provider
I do not routinely make referrals for medical conditions
Other
9. Do you know a place where you can refer a patient for the following?
1 Yes
a

HPV educational information
b HPV vaccination
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0

No

10. How much do you agree or disagree with the following statements?
strongly
disagree

0
a
b
c
d

1

disagree

2

agree

3 strongly

agree

HPV is a sexually transmitted
disease (STD)
HPV is preventable
HPV causes cancer in females
HPV causes cancer in males

11. Please indicate how much you agree or disagree with each of the following
statements: If I offered HPV educational intervention to my patients…
0 strongly

disagree
a
b
c
d

1

disagree

2

agree

3

strongly
agree

I would feel that I am acting in the best
interest of the patient
My colleagues’ perception of me as an
orthodontist would improve
My patients’ perception of me as an
orthodontist would improve
I would be afraid I would offend my
patients

12. If you were to contribute to a public health effort aimed at increasing the HPV
vaccination rates among adolescent patients, please answer how much you agree or
disagree with the following statements.
0

strongly
disagree
a
b
c
d

e
f

I need additional knowledge about HPV
prevention
I don’t know where to refer patients for the
HPV vaccine
I need information about HPV vaccine
administration
I would offer HPV educational intervention
even if third party reimbursement was not
available
I need information on how to discuss HPV
effectively with my patients
Orthodontists, as dentists, have
responsibilities for overall patient health and
not just health of the oral cavity
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3
1

disagree

2

agree

strongly
agree

13. Regarding the possibility of offering HPV educational intervention in your
practice, how much do you agree or disagree with the following statements?
0

1

strongly
disagree
a

b
c
d
e

disagree

2

agree

3

strongly
agree

My patients and/or their parents are amenable
to HPV educational intervention in the
orthodontic setting
It would make my patients and/or their
parents uncomfortable if I discussed HPV
I would feel comfortable talking with my
patients and/or their parents about HPV
HPV is out of the scope of practice for an
orthodontist
I expect reimbursement for my HPV
educational intervention

14. How important do you regard each of the following?
2

a

Communication with your patients and
their parents regarding HPV

b

Vaccination of children between the
ages of 11 and 12 years for HPV

0 not

1 somewhat

important at
all

unimporta
nt

somewha
t
importan
t

3 very
important

15. Please indicate how much you agree or disagree with each of the following
statements. If I offered the HPV vaccine to my patients…
0 strongly

disagree
a
b
c
d

I would feel that I am acting in the best
interest of the patient
My colleagues’ perception of me as an
orthodontist would improve
My patients’ perception of me as an
orthodontist would improve
I would be concerned about negative
reactions from my patients
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1

disagree

2 agree

3 strongly

agree

16. Are you Hispanic / Latino?
Yes
No
17. What is your gender?
Male
Female
Other
18. What is your race?
White
Black or African American
Asian
American Indian or Alaska Native
Native Hawaiian or Pacific Islander
Other
19. What is your age (years)?

20. What year did you graduate from your Postgraduate Orthodontic Residency
Program?

21. How many years have you practiced Orthodontics exclusively?
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22. Which ONE of the following geographic descriptors best describes your
PRIMARY current practice?
Urban
Rural

23. Which ONE of the following structural descriptors best describes your PRIMARY
current practice?
Solo practice
Group practice
24. Which ONE of the following settings best describes your PRIMARY current
practice?
Private practice
University-based practice
Public health practice
25. Please approximate the percent of the patients in your office that fall within the
following age categories (Please respond by entering percentages between: 0 –
100%).

a
b

Ages
17 years of age or younger
18 years of age or older

Percent (%)

26. Which one response best describes the number of patients you see in your office
daily?
0-25
26-50
51-75
76-100
100+
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27. How much office time are you willing to spend to provide an HPV educational
intervention to your patients?
not willing
less than 1 minute
1-2 minutes
3-4 minutes
5 minutes or more

28. Please indicate how much you agree or disagree with the following statements
regarding the delivery of HPV educational intervention to your patients?
strongly
disagree

0
a

b
c

1

disagree

3
2 agree

strongly
agree

It is the responsibility of the orthodontist to
deliver the educational intervention
personally
Delivering educational intervention can be
delegated to a chairside assistant
Delivering educational intervention can be
delegated to a treatment coordinator and/or
office manager

29. Do you have any comments on providing patients with HPV education, HPV
vaccination referrals, availability of training materials, and/or other chairside
medical screenings in the orthodontic care setting? Please let us know below.
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
______________________________________________________________________________________
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